
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epidemiological projections of viral‐induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination
Erwan Vo Quang, Yusuke Shimakawa, Pierre Nahon
Liver International (2021) Vol. 41, Iss. 5, pp. 915-927
Open Access | Times Cited: 35
Erwan Vo Quang, Yusuke Shimakawa, Pierre Nahon
Liver International (2021) Vol. 41, Iss. 5, pp. 915-927
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
Xiaoxi Ouyang, Longxian Lv, Yalei Zhao, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 28
Xiaoxi Ouyang, Longxian Lv, Yalei Zhao, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 28
Advances in multi-omics research on viral hepatitis
Ze Xiang, Jiayuan Li, Di Lu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 25
Ze Xiang, Jiayuan Li, Di Lu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 25
Trends in Incidence and Prognostic Factors of Two Subtypes of Primary Liver Cancers: A Surveillance, Epidemiology, and End Results-Based Population Study
Jiping Yao, Xue Liang, Yanning Liu, et al.
Cancer Control (2022) Vol. 29
Open Access | Times Cited: 22
Jiping Yao, Xue Liang, Yanning Liu, et al.
Cancer Control (2022) Vol. 29
Open Access | Times Cited: 22
Both Full-Length and Protease-Cleaved Products of Osteopontin Are Elevated in Infectious Diseases
Toshio Hattori, Hiroko Iwasaki, Gaowa Bai, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1006-1006
Open Access | Times Cited: 24
Toshio Hattori, Hiroko Iwasaki, Gaowa Bai, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 1006-1006
Open Access | Times Cited: 24
Association of Nationwide Hepatitis B Vaccination and Antiviral Therapy Programs With End-Stage Liver Disease Burden in Taiwan
Chun‐Ju Chiang, Jing‐Rong Jhuang, Ya‐Wen Yang, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2222367-e2222367
Open Access | Times Cited: 17
Chun‐Ju Chiang, Jing‐Rong Jhuang, Ya‐Wen Yang, et al.
JAMA Network Open (2022) Vol. 5, Iss. 7, pp. e2222367-e2222367
Open Access | Times Cited: 17
SPINK13 acts as a tumor suppressor in hepatocellular carcinoma by inhibiting Akt phosphorylation
Yongzhi Lun, Jie Sun, Ling Wei, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access | Times Cited: 2
Yongzhi Lun, Jie Sun, Ling Wei, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access | Times Cited: 2
Synthetic Tryptanthrin Derivatives Induce Cell Cycle Arrest and Apoptosis via Akt and MAPKs in Human Hepatocellular Carcinoma Cells
Jing-Yan Gao, Chih‐Shiang Chang, Jin‐Cherng Lien, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1527-1527
Open Access | Times Cited: 13
Jing-Yan Gao, Chih‐Shiang Chang, Jin‐Cherng Lien, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1527-1527
Open Access | Times Cited: 13
CENPO is Associated with Immune Cell Infiltration and is a Potential Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
Kun He, Mengyi Xie, Jingdong Li, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 7493-7510
Open Access | Times Cited: 8
Kun He, Mengyi Xie, Jingdong Li, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 7493-7510
Open Access | Times Cited: 8
Viral Infections of the Fetus and Newborn
Caleb Stokes, Ann J. Melvin
Elsevier eBooks (2023), pp. 450-486.e24
Closed Access | Times Cited: 4
Caleb Stokes, Ann J. Melvin
Elsevier eBooks (2023), pp. 450-486.e24
Closed Access | Times Cited: 4
Screening rates for hepatitis B and C among low‐income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study
Hind A. Beydoun, Jack Tsai
Journal of Viral Hepatitis (2024) Vol. 31, Iss. 10, pp. 601-613
Closed Access | Times Cited: 1
Hind A. Beydoun, Jack Tsai
Journal of Viral Hepatitis (2024) Vol. 31, Iss. 10, pp. 601-613
Closed Access | Times Cited: 1
Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques
Shivani Kale, Geeta Karande, Anand Gudur, et al.
Cureus (2024)
Open Access | Times Cited: 1
Shivani Kale, Geeta Karande, Anand Gudur, et al.
Cureus (2024)
Open Access | Times Cited: 1
Immunotherapy Responses in Viral Hepatitis-Induced HCC: A Systematic Review and Meta-Analysis
Junaid Anwar, Hafiz Muhammad Arslan, Zouina Sarfraz, et al.
Current Oncology (2024) Vol. 31, Iss. 11, pp. 7204-7225
Open Access | Times Cited: 1
Junaid Anwar, Hafiz Muhammad Arslan, Zouina Sarfraz, et al.
Current Oncology (2024) Vol. 31, Iss. 11, pp. 7204-7225
Open Access | Times Cited: 1
Fc fragment of IgG binding protein is correlated with immune infiltration levels in hepatocellular carcinoma
Yuhong Suo, Chunyu Hou, Guang Yang, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 3
Yuhong Suo, Chunyu Hou, Guang Yang, et al.
Biomolecules and Biomedicine (2023)
Open Access | Times Cited: 3
Identification of potential pseudogenes for predicting the prognosis of hepatocellular carcinoma
Luqi Ge, Tiefeng Jin, Wanli Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 14255-14269
Open Access | Times Cited: 3
Luqi Ge, Tiefeng Jin, Wanli Zhang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 15, pp. 14255-14269
Open Access | Times Cited: 3
L-distance ratio: a new distance ratio-based evaluation method for the diagnosis of cirrhosis using enhanced computed tomography
Huifen Ye, Qiushi Wang, Haitao Huang, et al.
Quantitative Imaging in Medicine and Surgery (2023) Vol. 13, Iss. 3, pp. 1499-1509
Open Access | Times Cited: 2
Huifen Ye, Qiushi Wang, Haitao Huang, et al.
Quantitative Imaging in Medicine and Surgery (2023) Vol. 13, Iss. 3, pp. 1499-1509
Open Access | Times Cited: 2
Mapping evidence on the risk factors associated with pediatric cancers in sub-Saharan Africa: a scoping review
Sehlisiwe R. Ndlovu, Mbuzeleni Hlongwa, Themba G. Ginindza
Systematic Reviews (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 4
Sehlisiwe R. Ndlovu, Mbuzeleni Hlongwa, Themba G. Ginindza
Systematic Reviews (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 4
Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals
Ginny Jacobs, Deborah A. Boyle, Hashem B. El–Serag, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 3670-3683
Open Access | Times Cited: 4
Ginny Jacobs, Deborah A. Boyle, Hashem B. El–Serag, et al.
Cancer Medicine (2022) Vol. 12, Iss. 3, pp. 3670-3683
Open Access | Times Cited: 4
Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa
Jeanne Perpétue Vincent, Gibril Ndow, Shintaro Ogawa, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 4
Jeanne Perpétue Vincent, Gibril Ndow, Shintaro Ogawa, et al.
Journal of Global Health (2022) Vol. 12
Open Access | Times Cited: 4
Review: Challenges of In Vitro CAF Modelling in Liver Cancers
Alba Herrero, Elisabeth Knetemann, Inge Mannaerts
Cancers (2021) Vol. 13, Iss. 23, pp. 5914-5914
Open Access | Times Cited: 5
Alba Herrero, Elisabeth Knetemann, Inge Mannaerts
Cancers (2021) Vol. 13, Iss. 23, pp. 5914-5914
Open Access | Times Cited: 5
Comparison of post-resection survival between hepatocellular carcinoma patients in BCLC stage A or B who experience tumor rupture and patients in BCLC stage C who do not
Su Jia-Yong, Hongliang Wang, Luo Ding-Wen, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27355-e27355
Open Access
Su Jia-Yong, Hongliang Wang, Luo Ding-Wen, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27355-e27355
Open Access
PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma
Wenzhi Jin, Ganggang Wang, Meiyuan Dong, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Wenzhi Jin, Ganggang Wang, Meiyuan Dong, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
A Longitudinal Analysis of Mortality Related to Chronic Viral Hepatitis and Hepatocellular Carcinoma in the United States
Nazlı Begüm Öztürk, Hoang Nhat Pham, Rama Mouhaffel, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 694-694
Open Access
Nazlı Begüm Öztürk, Hoang Nhat Pham, Rama Mouhaffel, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 694-694
Open Access
Role of Epigenetic Factors in Determining the Biological Behavior and Prognosis of Hepatocellular Carcinoma
Sami Akbulut, Zeynep Küçükakçalı, Tevfik Tolga Şahin, et al.
Diagnostics (2024) Vol. 14, Iss. 17, pp. 1925-1925
Open Access
Sami Akbulut, Zeynep Küçükakçalı, Tevfik Tolga Şahin, et al.
Diagnostics (2024) Vol. 14, Iss. 17, pp. 1925-1925
Open Access
Hepatocellular Carcinoma (HCC) in the UAE
Salman Wahib Srayaldeen, Mohamed Ahmed Mohamed Elkhalifa
(2024), pp. 491-534
Open Access
Salman Wahib Srayaldeen, Mohamed Ahmed Mohamed Elkhalifa
(2024), pp. 491-534
Open Access
Cell therapy using anti-NKG2A pretreated natural killer cells in patients with hepatocellular carcinoma
Saeed Nazari Tavakoli, Maryam Samareh Salavatipour, Shahrokh Abdolahi, et al.
Advanced Pharmaceutical Bulletin (2024)
Open Access
Saeed Nazari Tavakoli, Maryam Samareh Salavatipour, Shahrokh Abdolahi, et al.
Advanced Pharmaceutical Bulletin (2024)
Open Access